Navigation Links
Chem Rx Corporation Reports Full Year 2007 Financial Results
Date:4/3/2008

that was not acquired in the

transaction.

(f) Reflects adjustment for assumed corporate tax rate of 40%.

(g) Reflects depreciation & amortization of Chem Rx Corporation, excluding

contribution of 750 Park Place. 750 Park Place is an affiliate that

was not acquired in the transaction.

(h) Reflects 1) non-recurring expenses related to the operations of Chem

Rx Corporation prior to the acquisition of B.J.K. Inc. and 2) certain

professional fees and other expenses not related to the ongoing

operations of B.J.K. Inc.

Pro Forma Adjusted EBITDA is not a measurement of financial performance

under generally accepted accounting principles (GAAP) and should not be

considered as a measure of liquidity or as an alternative to operating

income, net income or cash flow from operating activities as indicators of

operating performance or any other measures of performance derived in

accordance with GAAP.

Chem Rx Corporation U.S. GAAP to Non-GAAP Measure Reconciliation

PRO FORMA ADJUSTED EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION &

AMORTIZATION (PRO FORMA ADJUSTED EBITDA)

For the Year Ended December 31, 2006

(Figures in thousands)

MANAGEMENT NON-GAAP U.S. GAAP NON-GAAP

MEASURES MEASURE PRO FORMA ADJUSTMENTS MEASURE

(Unaudited) (Unaudited)

Chem Rx Chem Rx

Corporation B.J.K. Inc. Corporation

U.S. GAAP U.S. GAAP Non-GAAP

Period Ended Period Ended Non-GAAP Pro Forma

December 31, October 26, Other December 31,

2006 2006 Adjustments 2006
'/>"/>

SOURCE Chem Rx Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
2. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
3. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
4. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
5. BioElectronics Corporation Announces Singapore and Malaysia Sales
6. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
7. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
8. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
9. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
10. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
11. Enova Medical Launches Exos Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... -- Senior Vice President, General Manager for ... business acumen Elsevier , a world-leading ... services, congratulates Diane Bartoli , Senior Vice President ... Clinical Solutions, for being recognized in the 13 th ... of Profiles in Diversity Journal ® . ...
(Date:11/22/2014)... MA (PRWEB) November 21, 2014 ... key investors will gather on December 3rd at ... Biotech Conferences series. GeneticRx will take place at ... Medical School and will discuss the present and ... therapy, exon skipping, and gene editing—as well as ...
(Date:11/22/2014)... November 22, 2014 The “Chiral ... Preparative), by Material (Metal, Glass, Plastic), by Application ... SFC] - Forecast to 2018” analyses and studies ... in North America, Europe, Asia, and Rest of ... and 15 figures spread through 135 pages and ...
(Date:11/21/2014)... , Todd Martensen ... Mariano Rodríguez es elegid vicepresidente senior de desarrollo empresarial ... en marcha para comenzar de forma rápida la comercialización de ... aprobación en Europa   , KLOX ... los siguientes nombramientos: Todd Martensen ha ...
Breaking Biology Technology:Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 2Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 3Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 3Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 4Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 5KLOX Technologies anuncia sus nombramientos ejecutivos 2KLOX Technologies anuncia sus nombramientos ejecutivos 3KLOX Technologies anuncia sus nombramientos ejecutivos 4KLOX Technologies anuncia sus nombramientos ejecutivos 5
... Pharmaceuticals,(Nasdaq: VIAP ), a biotechnology company focused on ... announced today that,James G. Stewart, senior vice president and ... Rodman & Renshaw 5th Annual Global,Healthcare Conference on Monday, ... Beach Plaza Hotel in Monte Carlo, Monaco., ...
... Health, a,leading allograft bio-implant company announces that Lloyd ... award at the 11th,Annual Hampton Roads Technology Council,s ... in Innovation award, sponsored by Willcox and Savage,P.C., ... from within,the Hampton Roads region. Hampton Roads Technology ...
... BCRX ) today announced financial results for,the quarter ended March ... quarter of 2008, compared to $9.2M in the first quarter ... 2008 was $13.1M, or,$0.34 per share, compared to a net ... $0.30 per share., Research and development (R&D) expenses were ...
Cached Biology Technology:LifeNet Health Chief Scientific Officer Wins Award 2BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 2BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 3BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 4BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 5BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 6BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 7BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 8
(Date:11/18/2014)... 2014   EyeLock Inc. , a market ... MorphoTrust USA (Safran), a leading U.S. provider ... strategic partnership to offer comprehensive biometric identity solutions ... airport screening and financial services markets. ... consumers through a nationwide network of 1,100 IdentoGO® ...
(Date:11/7/2014)... Dr. Debra Auguste, associate professor, biomedical engineering, in ... College of New York, have identified a molecule ... of the most aggressive forms of breast cancer. ... high mortality rate owing to aggressive proliferation and ... However, Professor Auguste,s team, discovered the overexpression of ...
(Date:11/6/2014)... PITTSBURGH--Speed is an asset for a predator. Except when that ... The tiger beetle, relative to its size, is the fastest ... 120 body lengths per second (at about five miles per ... To take the sprinting gold from the tiger beetle, a ... BUT! The tiger beetle has a problem. At peak speeds, ...
Breaking Biology News(10 mins):EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3The tiger beetle: Too fast to see 2
... been described as "molecular switches" and play a role ... and multiple other common cellular functions. Understanding ... cellular mechanisms related to cancer, which is fundamentally a ... rapidly, multiply and migrate into inappropriate places in the ...
... pain (or lumbago) is a common ailment often triggered by something ... to remedy the situation? An exercise machine designed specifically for back ... in the Journal of the American College of Sports Medicine ... help the development and endurance of back muscles, you must focus ...
... his groundbreaking research focusing on population biology and ecology ... researcher Dr. David Secor has been awarded the University ... for Excellence. As a fisheries biologist, a large ... that often have management conflicts: striped bass, bluefin tuna, ...
Cached Biology News:Research pinpoints action of protein linked to key molecular switch 2Exercise therapy for low back pain 2UMCES fisheries biologist Dr. David Secor receives USM Regent's Faculty Award for research 2
Mouse monoclonal [SPM302] to BCAR1, prediluted ( Abpromise for all tested applications). entrezGeneID: 9564 SwissProtID: P56945...
...
p21 Ras Immunogen: Recombinant C-H-ras p21(val-12). Storage: 4 C...
Rabbit polyclonal to Myosin VIIa (rating: *****) ( Abpromise for all tested applications). entrezGeneID: 4647 SwissProtID: Q13402...
Biology Products: